EGFR and non-small cell lung carcinoma: We found only 1 study that directly compared the efficacy of LATs and MTTs on oligo-recurrence in patients with EGFR-mutated NSCLC, but this previous study also found no significant difference in PR-OS between LAT and MTT [28].